Vistoplex is a pharmaceutical digital marketing agency for pharma, biotech, consumer health, medtech and life sciences organisations that need stronger visibility without treating regulation as an afterthought. We connect SEO, paid media, compliant websites, scientific content, analytics and multilingual delivery around the audience and approval route for each campaign.
The same website may need to inform patients, support healthcare professionals, reassure procurement teams, attract research partners and explain the company to investors. Each audience has different questions, evidence needs, permissions and conversion actions.
Public, patient, HCP, payer, partner and investor content cannot be treated as interchangeable. We map the intended audience before choosing the channel, page and call to action.
Search-friendly copy is not enough. Product, efficacy, safety and comparative statements need an agreed evidence basis and must stay within the approved context.
A good pharma marketing company plans for medical, legal and regulatory review from the first wireframe. It does not finish the creative and then discover it cannot be approved.
Audience targeting, forms, CRM data and remarketing need privacy-by-design. We minimise data collection and do not use inferred health status as an easy targeting shortcut.
Terminology, approved claims, search behaviour, mandatory information and channel availability vary by market. A global master cannot simply be translated and published everywhere.
Page views alone cannot show whether a campaign is working. We define meaningful actions for each audience: resource use, qualified enquiries, HCP engagement, partner interest and approved conversion events.
The commercial goal, permitted message and buying journey are different across prescription medicines, consumer healthcare, biotech, digital health and pharmaceutical supply. We build the programme around that difference.
Corporate websites, HCP journeys, disease-awareness resources, medical education pathways, congress support and professional campaign measurement.
Search strategy, product education, ecommerce and retailer support, paid media, landing pages and claim-aware creative aligned to the authorised product position.
Pipeline storytelling, corporate reputation, investor and partner visibility, trial recruitment support, scientific content and pharma startup branding services.
Technical positioning, evidence-led product pages, procurement journeys, demos, app or platform marketing and international search architecture.
B2B lead generation for development, manufacturing, testing, packaging and supply services—built around technical capability and procurement intent.
Portfolio visibility, account acquisition, supplier credibility, ecommerce or ordering journeys, content for buyers and CRM-connected lead management.
Pharmacy digital marketing with separate strategies for consultations, OTC categories, local search, patient information, ecommerce and regulated treatment journeys.
Search and content programmes for research, clinical operations, regulatory, market access, pharmacovigilance and specialist consultancy services.
Vistoplex brings SEO, websites, PPC, CRM, analytics and social into one connected pharmaceutical growth programme, with audience permissions, evidence, approval, localisation and measurement built into the strategy from the start.
Technical SEO, search architecture and scientific content built around corporate, HCP, disease, service and product-category intent.
Clear content for complex subjects, drafted from approved source material and structured for search, comprehension and review.
Paid search, LinkedIn, display and remarketing strategies aligned to the product, audience, platform policy and approved campaign route.
Fast, accessible websites with audience separation, gated areas, approved content modules, consent controls and analytics planned from the wireframe.
Positioning, visual identity and launch systems that make complex science understandable without oversimplifying the evidence.
Approved content calendars for corporate reputation, employer brand, congress activity, thought leadership and permitted audience engagement.
Lead routing, review notifications, asset status, approved content reuse and reporting automations that reduce repetitive work without removing oversight.
Measurement frameworks that distinguish useful professional or commercial actions from superficial traffic growth.
Native search research, market adaptation and multilingual content across 30 languages, with local review and terminology control.
A strong digital pharmaceutical marketing agency does not send every visitor into the same generic funnel. It defines audience, information need, permitted content and next action before media or creative production begins.
| Audience | Typical information need | Useful digital assets | Primary guardrail | Meaningful action |
|---|---|---|---|---|
| Patients and publicCondition understanding, support, access routes and balanced corporate information. | Plain-language disease education, support resources, corporate pages and permitted OTC information. | Public website, organic search, approved social, email where consent permits. | Do not promote prescription-only medicines to the public; keep information balanced and non-promotional. | Resource use, support contact, permitted consultation or service action. |
| Healthcare professionalsClinical evidence, product information, education, congress resources and service support. | HCP portals, eDetails, approved emails, webinars, evidence summaries and downloadable resources. | Professional search, gated content, approved email, LinkedIn and specialist media. | Professional status, prescribing information, approved claims and required disclosures. | Verified registration, resource engagement, meeting or medical-information request. |
| Payers and procurementValue, outcomes, supply, implementation, contracting and organisational capability. | Value narratives, technical service pages, evidence libraries, capability decks and tender support. | SEO, account-based paid media, LinkedIn, email and direct sales enablement. | Claims must remain accurate, supportable and appropriate for the intended decision maker. | Qualified enquiry, supplier discussion, document request or meeting. |
| Partners and investorsPipeline, platform, science, leadership, milestones and collaboration opportunity. | Corporate website, pipeline pages, news, investor content, conference landing pages and partner materials. | Corporate SEO, PR, LinkedIn, email and event campaigns. | Consistency with public disclosures, approved corporate statements and market-sensitive information controls. | Partner enquiry, investor resource use, talent application or meeting. |
We build a controlled production route around your authorised reviewers, making approvals easier to manage, decisions easier to trace and release status clear across every campaign asset.
UK medicines advertising: the route depends on product classification and audience. Prescription-only medicines cannot be advertised to the general public, while promotion to healthcare professionals is governed by medicines law and the industry code. OTC communications still need authorised, supportable claims and the required information.
Digital media is not exempt: websites, paid ads, social posts, influencer activity, emails and landing pages can all be advertising. Platform targeting does not replace an audience-permission decision.
Privacy matters at campaign level: health data is special-category personal data. Forms, pixels, audiences, CRM fields and remarketing plans should be reviewed before launch, particularly where health status could be collected or inferred.
Safety and medical-information routes must be agreed: social comments, forms and inboxes can surface adverse-event or medical-information content. We define who receives it and how it is escalated; we do not silently leave it inside a marketing inbox.
Strong pharmaceutical marketing protects the integrity of claims, audience permissions and personal data while creating clear, measurable paths to growth.
Disease-awareness and support content must be genuinely informational and separated from impermissible product promotion.
Creative optimisation stays inside the approved evidence and authorised context. Performance does not validate an unsupported claim.
Audience strategy must respect privacy, special-category data rules, platform policy and the expectations of the people being reached.
AI may support controlled research, variation or workflow tasks, but medical accuracy, sources, claims and approval require accountable human review.
Cross-sector technical capabilities can be valuable, while sector experience, outcomes and examples are always presented with the correct context.
No agency controls search algorithms. We commit to the strategy, implementation, content, technical work and measurement—not a result nobody can ethically guarantee.
This industry hub targets commercial demand for a pharma marketing agency. The campaigns we deliver then need a deeper site architecture that answers real questions across the organisation’s permitted content landscape.
Pages that explain the organisation, its value and the reasons a partner, buyer, investor or candidate should take the next step.
Resources organised around the questions people ask, the evidence they need and the content they are permitted to access.
The process is designed to prevent expensive rework. Strategy, evidence, audience permissions and review responsibilities are settled before full production begins.
We define product status, markets, audiences, business goals, existing approvals, systems and current performance.
We separate public, HCP, payer, partner and corporate routes, then define the information and action for each.
Approved source materials, claims, references, terminology and content priorities are turned into a controlled production brief.
Copy, design and development progress together so references, gates, disclosures and analytics fit the experience.
Comments are consolidated, versions controlled, approvals recorded and final assets tested before publication.
We optimise approved elements, content gaps, UX, media efficiency and technical performance without stepping outside the agreed route.
The measurement plan changes with the audience and objective. A patient-resource page, HCP portal, CDMO service page and biotech investor site should not share the same definition of success.
Non-brand visibility, qualified organic sessions, content coverage, technical health and the proportion of priority queries reaching commercially or scientifically useful pages.
Verified registrations, evidence-resource use, webinar or congress actions, meeting requests and medical-information contacts—within the approved tracking plan.
Procurement, partnership, distribution, licensing and service enquiries segmented by source, market, content path and qualification outcome.
Approved reach, search-term quality, landing-page conversion, cost per qualified action, excluded traffic and wasted-spend reduction.
Approval cycle time, first-review acceptance, amendment volume, content reuse, expiry risk and the backlog of priority pages awaiting evidence or review.
Market and language visibility, local query coverage, engagement quality, hreflang integrity and performance by regional content version.
We do not hide every number until a sales call. The rates below are Vistoplex’s standard service starting points. A regulated pharmaceutical programme is quoted after discovery because audience controls, medical writing, MLR rounds, localisation and technical requirements can materially change the scope.
For a focused UK search programme. International SEO starts from £1,499/month.
National campaign management, excluding media spend. Complex regulated campaigns are scoped separately.
For standard brochure and lead-generation websites. Portals, multilingual builds and custom workflows are quoted to scope.
Purpose-built paid-media or campaign pages, including message alignment, form flow and tracking.
Standard Vistoplex starting rate. Pharma governance, review and moderation requirements are added to scope.
For joined-up SEO, paid media, content, web, analytics, localisation and workflow support.
We work with standard search, analytics, CRM and behaviour tools, then fit the workflow around your CMS, review platform, medical-information route, pharmacovigilance process and security requirements.
Search, content, websites, paid media, data and workflow are designed together so the campaign does not fragment across unrelated suppliers.
Gated content, CMS permissions, analytics governance, dashboards, integrations and custom workflows are engineering tasks—not lines in an audit nobody owns.
Native and professional-level language support helps international pharmaceutical marketing move beyond literal translation.
We publish starting prices, explain what changes the scope and distinguish what we control from what we do not.
Recommendations are tied to search data, audience needs, evidence, conversion logic and official guidance—not agency preference.
If the bottleneck is evidence, internal approval, platform access or sales follow-up rather than marketing volume, we tell you before adding spend.
Tell us the product category, intended audience, markets, current channels and approval process. We will identify the highest-value gaps across search, content, paid media, website experience and measurement before recommending a retainer.
